Short interest in Karyopharm Therapeutics Inc (NASDAQ:KPTI) decreased during the last reporting period, falling from 18.52M to 17.93M. This put 14.66% of the company's publicly available shares short.

Short interest for Karyopharm Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Karyopharm Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 520.43K shares traded per day, it would take 34.45 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.